Category

IBTA News

The IBTA lends support to the Brain Tumour Tissue Campaign

By IBTA News

Brain Tumour Tissue Campaign 150224

[24 February 2015]   We are pleased to support a new initiative by UK medical researchers and brain tumour charity brainstrust which seeks to raise awareness amongst patients and healthcare professionals about donating brain tumour tissue for research purposes. Availability of brain tumour tissue for research is crucial if we are to come closer to finding better treatments and ultimately a cure for this disease. You can find out more about the Brain Tumour Tissue Campaign here.

IBTA advisor published in New Scientist magazine

By IBTA News

[9 January 2015]   Dr Stuart Farrimond, the IBTA’s digital technology advisor, has written an article for New Scientist magazine titled “Radical therapies that could beat my brain tumour” (New Scientist, Issue No. 3003, 10 January 2015). As a former practising medical doctor, and a brain tumour survivor, Stu offers an insightful look at four of the most promising brain tumour treatments currently in development.

You can read his article in full here.

The IBTA Exhibits at SNO 2014 in Miami

By IBTA News

[30 November 2014]   The Society for Neuro-Oncology 2014 Annual Meeting (SNO 2014) was held in Miami, Florida on 13-16 November 2014. Over 1,900 delegates from 43 countries attended the conference, confirming it as the largest and most important neuro-oncology-specific event of the year.

A major highlight of the conference was the presentation by Dr Roger Stupp of the interim results from Novocure’s phase III clinical trial in newly diagnosed GBM (EF-14). The overall survival (OS) data was very positive and has resulted in early termination of the trial due to success. Other highlights included presentations on: Celldex Therapeutics’ immunotherapy treatment, rindopepimut; the use of bevacizumab (Avastin) and lomustine in recurrent GBM; the addition of PCV (procarbazine, CCNU and vincristine) to radiotherapy for the treatment of low grade gliomas; and the genomic characterisation of diffuse low grade gliomas. All of these studies may eventually lead to changes in clinical practice.

The IBTA was recognised with a SNO Public Service Award presented in absentia to the former chair, Denis Strangman (Australia). Our full report from the conference can be downloaded here.

The IBTA reports on the EANO 11th Annual Congress in Turin

By IBTA News

Nearly one thousand healthcare and allied professionals, including numerous key researchers and policy leaders from around the world, attended the biennial European Association of Neuro-Oncology (EANO) meeting this month. Held in the Lingotto Conference Centre in Turin, Italy, from 9th to 12th October 2014, the conference theme was: “Analysing the Past to do Better in the Future”.

Read our full conference report here.

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.